Public reporting on pharmaceutical industry-led access programs: alignment with the WHO medicine programs evaluation checklist

References

• Rockers PC, Wirtz VJ, Umeh CA, Swamy PM, Laing RO. Industry-led access-to-medicines programs in low-and middle-income countries: strategies and evidence. Health Aff. 2017;36(4):706–713.
   Web of Science ®Google Scholar
• Fürst M. Reframing the pharmaceutical sector contribution to access to medicines and universal health coverage: a business ethics perspective. In: Sturchio JL, Kickbusch I, Galambos L, editors. The road to universal health coverage: innovation, equity, and the new health economy. Baltimore (MD): Johns Hopkins University Press; 2019.
   Google Scholar
• Nusser H. Novartis social business: a novel approach to expanding health care in developing countries. In: Sturchio JL, Kickbusch I, Galambos L, editors. The road to universal health coverage: innovation, equity, and the new health economy. Baltimore (MD): Johns Hopkins University Press; 2019.
   Google Scholar
• Clarke D, Doerr S, Hunter M, Schmets G, Soucat A, Paviza A. The private sector and universal health coverage, 2019. Bull World Health Organ. 97:434–5. https://doi.org/10.2471/BLT.18.225540.
   Google Scholar
• World Health Organization. Responding to industry programs to increase access to medicines and other health technologies in countries. In: EMP policy brief series no. 2.0; 2017. Accessed August 22, 2018 from http://apps.who.int/medicinedocs/documents/s23358en/s23358en.pdf.
   Google Scholar
• Asante AD, Zwi AB. Public-private partnerships and global health equity: prospects and challenges. Indian J Med Ethics. 2007;4(4):176–180.
   PubMedGoogle Scholar
• Buse K, Walt G. Reich MR, The World Health Organization and global public-private health partnerships: in search of ‘good’ Global Health governance. In: editor. Public-private partnerships for public health. Harvard series on population and international health. 2002:1–8. Accessed December 31, 2018 from https://cdn1.sph.harvard.edu/wp-content/uploads/sites/480/2012/09/Partnerships_book.pdf.
   Google Scholar
• World Health Organization, 2019. Accountability. Accessed January 14 2020 from https://www.who.int/health-laws/topics/governance-accountability/en/.
   Google Scholar
• Brinkerhoff DW. Accountability and health systems: towards conceptual clarity and policy relevance. Health Policy Plan. 2004;19(6):371–379.
   PubMed Web of Science ®Google Scholar
• O’Malley P, Rainford J, Thompson A. Transparency during public health emergencies: from rhetoric to reality. Bull World Health Organ. 2009;87:614–618.
   PubMed Web of Science ®Google Scholar
• Access Observatory. Accessed February 19 2019 from https://www.accessobservatory.org/.
   Google Scholar
• Access to Medicine Index 2018. Methodology report. Accessed September 14 2018 from https://accesstomedicineindex.org/media/atmi/2017-Methodology-2018-Access-to-Medicine-Index.pdf.
   Google Scholar
• IFPMA Partnerships Directory. Accessed February 13 2019 from http://partnerships.ifpma.org/pages/.
   Google Scholar
• Access Accelerated Open Platform. Accessed February 19 2019 from https://aaopenplatform.accessaccelerated.org/#!/layouts/home.html.
   Google Scholar
• Hooper PD, Greenall A. Exploring the potential for environmental performance benchmarking in the airline sector. Benchmarking. 2005;12:151–165.
   Google Scholar
• Global Reporting. Reporting on community impacts. In: A survey conducted by the global reporting initiative: The University of Hong Kong and CSR Asia; 2008. Accessed January 14 2020 from https://www.globalreporting.org/resourcelibrary/Reporting-on-Community-Impacts.pdf.
   Google Scholar
• de Grosbois D. Corporate social responsibility reporting by the global hotel industry: commitment, initiatives and performance. Int J Hosp Manag. 2012;31:896–905.
   Web of Science ®Google Scholar
• Rockers PC, Reich MR, Kettler H, Wirtz VJ. Commitment to impact: strengthening measurement of industry-led access-to-medicines programs. Health Syst Reform. 2018;4(3):188–193.
   PubMed Web of Science ®Google Scholar
• Schell SF, Luke DA, Schooley MW, Elliott MB, Herbers SH, Mueller NB, et al. Public health program capacity for sustainability: a new framework. Implement Sci. 2013 Feb 1;8(1):1.
   PubMedGoogle Scholar
• Blasinsky M, Goldman HH, Unützer J. Project IMPACT: a report on barriers and facilitators to sustainability. Adm Policy Ment Health Ment Health Serv Res. 2006;33(6):718–729.
   PubMed Web of Science ®Google Scholar
• Scheirer MA. Is sustainability possible? A review and commentary on empirical studies of program sustainability. Am J Eval. 2005;26(3):320–347.
   Web of Science ®Google Scholar
• Wright J, Williams R, Wilkinson JR. Health needs assessment: development and importance of health needs assessment. BMJ. 1998;316(7140):1310.
   PubMedGoogle Scholar
• Buse K, Walt G. Global public-private partnerships: part II-what are the health issues for global governance? Bull World Health Organ. 2000;78:699–709.
   PubMed Web of Science ®Google Scholar
• Kostyak L, Shaw DM, Elger B, Annaheim B. A means of improving public health in low-and middle-income countries? Benefits and challenges of international public–private partnerships. Public Health. 2017;149:120–129.
   PubMed Web of Science ®Google Scholar
• Walt G, Buse K. Partnership and fragmentation in international health: threat or opportunity? Tropical Med Int Health. 2000;5(7):467–471.
   PubMed Web of Science ®Google Scholar
• Shediac-Rizkallah MC, Bone LR. Planning for the sustainability of community-based health programs: conceptual frameworks and future directions for research, practice and policy. Health Educ Res. 1998;13(1):87–108.
   PubMed Web of Science ®Google Scholar
• Marmot M. Commission on social determinants of health. Achieving health equity: from root causes to fair outcomes. Lancet. 2007;370(9593):1153–1163.
   PubMed Web of Science ®Google Scholar
• United Nations sustainable development goals. Accessed August 23 2018 from https://www.un.org/sustainabledevelopment/inequality/.
   Google Scholar
• Rockers PC, Laing RO, Ashigbie PG, Onyango MA, Mukiira CK, Wirtz VJ. Effect of Novartis access on availability and price of non-communicable disease medicines in Kenya: a cluster-randomised controlled trial. Lancet Glob Health. 2019;7(4):e492–e502.
   PubMed Web of Science ®Google Scholar
• Sinkowitz-Cochran RL. Survey design: to ask or not to ask? That is the question. Clin Infect Dis. 2013;56(8):1159–1164.
   PubMed Web of Science ®Google Scholar
• Olson K. 2013. ‘Double-barreled question (online encyclopedia entry). In: Lavrakas PJ, editor. Encyclopedia of survey research methods. London: SAGE; 2008. Accessed January 11, 2019 from https://methods.sagepub.com/reference/encyclopedia-of-survey-research-methods/n145.xml.
   Google Scholar